Skip to main content

ImmunOncology™ VPI-101

VPI-101 – Lung Cancer

66%

VPI-101 - Melanoma

45%

VPI-101 - Glioblastoma

45%

VPI-101 - Melanoma + Checkpoint Inhibitor

45%

VPI-101 - Lung Cancer + Checkpoint Inhibitor

33%

VPI-101 - Colon Cancer

33%

VPI-101 - Breast Cancer

33%

VPI-101 – Pancreatic Cancer

33%

VPI-101 - Prostate Cancer

33%

VPI-101 - Head & Neck Cancer

33%

VPI-101 - Renal Cancer

33%

VPI-101 - Bladder Cancer

33%

VPI-101 - Graft Versus Host Disease

33%

ImmunOncology™ VPI 111, 121, 131, 141

VPI-111 (NY-ESO-Vault) – Lung Cancer

40%

VPI-111 (NY-ESO-Vault) - Glioblastoma

40%

VPI-121 (GP100-Vault) - Glioblastoma

40%

VPI-131 (IL7-Vault) - Lung Cancer

40%

VPI-131 (IL7-Vault) - Pulmonary Fibrosis

33%

VPI-141 (CCL19-Vault) - Solid Tumors

33%

ImmunActiv™ VPI 201, 211, 221, 231, 241, 251

VPI-201 (Chlamydia - Vault) – Chlamydia

40%

VPI-211 (HIV-Vault) - HIV/AIDS

40%

VPI-221 (Influenza-Vault) - Influenza

40%

VPI-251 (RSV-Vault) - HIV/AIDS

25%

VPI-241 (HPV) - HPV & HPV Cancers

24%

VPI-231 (Burk-Vault) - Burkholderia

25%